Annual FCF:
-$53.14M+$44.16M(+45.39%)Summary
- As of today, BCRX annual free cash flow is -$53.14 million, with the most recent change of +$44.16 million (+45.39%) on December 31, 2024.
- During the last 3 years, BCRX annual free cash flow has risen by +$91.40 million (+63.23%).
- BCRX annual free cash flow is now -1055.30% below its all-time high of -$4.60 million, reached on December 31, 1998.
Performance
BCRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$41.12M+$68.78M(+248.67%)Summary
- As of today, BCRX quarterly free cash flow is $41.12 million, with the most recent change of +$68.78 million (+248.67%) on June 30, 2025.
- Over the past year, BCRX quarterly free cash flow has increased by +$42.65 million (+2800.13%).
- BCRX quarterly free cash flow is now at all-time high.
Performance
BCRX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$15.76M+$42.65M(+158.62%)Summary
- As of today, BCRX TTM free cash flow is $15.76 million, with the most recent change of +$42.65 million (+158.62%) on June 30, 2025.
- Over the past year, BCRX TTM free cash flow has increased by +$101.56 million (+118.37%).
- BCRX TTM free cash flow is now at all-time high.
Performance
BCRX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BCRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +45.4% | +2800.1% | +118.4% |
| 3Y3 Years | +63.2% | +246.9% | +109.6% |
| 5Y5 Years | +40.9% | +232.2% | +115.2% |
BCRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +67.4% | at high | +176.3% | at high | +109.1% |
| 5Y | 5-Year | at high | +67.4% | at high | +152.6% | at high | +109.1% |
| All-Time | All-Time | -1055.3% | +67.4% | at high | +152.6% | at high | +109.1% |
BCRX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $41.12M(+248.7%) | $15.76M(+158.6%) |
| Mar 2025 | - | -$27.66M(-369.8%) | -$26.89M(+49.4%) |
| Dec 2024 | -$53.14M(+45.4%) | -$5.89M(-171.9%) | -$53.14M(+6.3%) |
| Sep 2024 | - | $8.19M(+637.5%) | -$56.73M(+33.9%) |
| Jun 2024 | - | -$1.52M(+97.2%) | -$85.80M(+17.1%) |
| Mar 2024 | - | -$53.92M(-469.2%) | -$103.56M(-6.4%) |
| Dec 2023 | -$97.31M(+40.4%) | -$9.47M(+54.6%) | -$97.31M(+13.3%) |
| Sep 2023 | - | -$20.88M(-8.3%) | -$112.21M(+9.5%) |
| Jun 2023 | - | -$19.28M(+59.6%) | -$123.95M(+6.6%) |
| Mar 2023 | - | -$47.67M(-95.6%) | -$132.67M(+18.7%) |
| Dec 2022 | -$163.20M(-12.9%) | -$24.38M(+25.3%) | -$163.20M(+5.3%) |
| Sep 2022 | - | -$32.62M(-16.5%) | -$172.39M(-5.5%) |
| Jun 2022 | - | -$28.00M(+64.2%) | -$163.41M(-1.1%) |
| Mar 2022 | - | -$78.21M(-133.0%) | -$161.64M(-11.8%) |
| Dec 2021 | -$144.54M(-6.6%) | -$33.57M(-42.0%) | -$144.54M(+5.9%) |
| Sep 2021 | - | -$23.64M(+9.8%) | -$153.66M(+8.8%) |
| Jun 2021 | - | -$26.22M(+57.1%) | -$168.45M(+2.8%) |
| Mar 2021 | - | -$61.11M(-43.2%) | -$173.34M(-27.8%) |
| Dec 2020 | -$135.62M(-50.8%) | -$42.69M(-11.1%) | -$135.62M(-31.1%) |
| Sep 2020 | - | -$38.43M(-23.5%) | -$103.46M(-11.5%) |
| Jun 2020 | - | -$31.11M(-33.0%) | -$92.76M(-7.6%) |
| Mar 2020 | - | -$23.40M(-122.2%) | -$86.23M(+4.1%) |
| Dec 2019 | -$89.93M(+3.2%) | -$10.53M(+62.0%) | -$89.93M(+13.1%) |
| Sep 2019 | - | -$27.72M(-12.7%) | -$103.49M(+6.6%) |
| Jun 2019 | - | -$24.59M(+9.2%) | -$110.84M(-10.5%) |
| Mar 2019 | - | -$27.09M(-12.5%) | -$100.33M(-8.0%) |
| Dec 2018 | -$92.93M(-124.1%) | -$24.09M(+31.3%) | -$92.93M(-16.9%) |
| Sep 2018 | - | -$35.07M(-149.1%) | -$79.48M(-39.4%) |
| Jun 2018 | - | -$14.08M(+28.5%) | -$57.02M(-8.3%) |
| Mar 2018 | - | -$19.69M(-85.1%) | -$52.63M(-26.9%) |
| Dec 2017 | -$41.47M(+29.4%) | -$10.63M(+15.7%) | -$41.47M(-13.0%) |
| Sep 2017 | - | -$12.62M(-30.3%) | -$36.69M(+12.2%) |
| Jun 2017 | - | -$9.69M(-13.6%) | -$41.81M(+7.4%) |
| Mar 2017 | - | -$8.53M(-45.7%) | -$45.14M(+23.1%) |
| Dec 2016 | -$58.72M(-221.9%) | -$5.85M(+67.0%) | -$58.72M(+18.2%) |
| Sep 2016 | - | -$17.74M(-36.2%) | -$71.74M(-7.4%) |
| Jun 2016 | - | -$13.02M(+41.1%) | -$66.80M(-85.3%) |
| Mar 2016 | - | -$22.10M(-17.1%) | -$36.05M(-97.7%) |
| Dec 2015 | -$18.24M(+52.8%) | -$18.87M(-47.4%) | -$18.24M(-36.9%) |
| Sep 2015 | - | -$12.80M(-172.2%) | -$13.32M(-45.5%) |
| Jun 2015 | - | $17.73M(+513.2%) | -$9.15M(+73.1%) |
| Mar 2015 | - | -$4.29M(+69.3%) | -$33.98M(+12.1%) |
| Dec 2014 | -$38.66M(-45.5%) | -$13.96M(-61.6%) | -$38.66M(-32.3%) |
| Sep 2014 | - | -$8.63M(-21.6%) | -$29.22M(-2.5%) |
| Jun 2014 | - | -$7.10M(+20.8%) | -$28.51M(-17.2%) |
| Mar 2014 | - | -$8.97M(-98.4%) | -$24.33M(+8.4%) |
| Dec 2013 | -$26.56M(+29.2%) | -$4.52M(+43.0%) | -$26.56M(+8.6%) |
| Sep 2013 | - | -$7.92M(-171.2%) | -$29.07M(+11.7%) |
| Jun 2013 | - | -$2.92M(+73.9%) | -$32.93M(+9.5%) |
| Mar 2013 | - | -$11.20M(-59.3%) | -$36.39M(+3.0%) |
| Dec 2012 | -$37.51M(-16.1%) | -$7.03M(+40.4%) | -$37.51M(-8.8%) |
| Sep 2012 | - | -$11.78M(-84.6%) | -$34.47M(-4.0%) |
| Jun 2012 | - | -$6.38M(+48.2%) | -$33.15M(-9.5%) |
| Mar 2012 | - | -$12.32M(-209.1%) | -$30.27M(+6.3%) |
| Dec 2011 | -$32.31M(-11.9%) | -$3.98M(+61.9%) | -$32.31M(+5.4%) |
| Sep 2011 | - | -$10.47M(-199.7%) | -$34.15M(-3.6%) |
| Jun 2011 | - | -$3.49M(+75.7%) | -$32.98M(+13.1%) |
| Mar 2011 | - | -$14.36M(-146.1%) | -$37.97M(-31.5%) |
| Dec 2010 | -$28.88M(-71.7%) | -$5.83M(+37.2%) | -$28.88M(-113.9%) |
| Sep 2010 | - | -$9.29M(-9.5%) | -$13.50M(-42.5%) |
| Jun 2010 | - | -$8.48M(-60.9%) | -$9.48M(+26.8%) |
| Mar 2010 | - | -$5.27M(-155.2%) | -$12.94M(+23.1%) |
| Dec 2009 | -$16.82M | $9.54M(+281.2%) | -$16.82M(+45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$5.27M(+55.9%) | -$30.98M(+3.4%) |
| Jun 2009 | - | -$11.94M(-30.5%) | -$32.08M(-20.7%) |
| Mar 2009 | - | -$9.15M(-98.6%) | -$26.58M(-20.3%) |
| Dec 2008 | -$22.09M(+22.1%) | -$4.61M(+27.6%) | -$22.09M(+36.9%) |
| Sep 2008 | - | -$6.37M(+1.2%) | -$34.97M(-1.2%) |
| Jun 2008 | - | -$6.45M(-38.2%) | -$34.56M(-17.8%) |
| Mar 2008 | - | -$4.67M(+73.3%) | -$29.33M(-3.5%) |
| Dec 2007 | -$28.34M(-69.2%) | -$17.50M(-194.0%) | -$28.34M(-7.7%) |
| Sep 2007 | - | -$5.95M(-389.1%) | -$26.32M(+21.6%) |
| Jun 2007 | - | -$1.22M(+66.9%) | -$33.56M(+27.3%) |
| Mar 2007 | - | -$3.67M(+76.3%) | -$46.17M(-175.7%) |
| Dec 2006 | -$16.75M(+28.4%) | -$15.47M(-17.2%) | -$16.75M(-142.8%) |
| Sep 2006 | - | -$13.20M(+4.5%) | -$6.90M(>-9900.0%) |
| Jun 2006 | - | -$13.83M(-153.7%) | $61.10K(-99.2%) |
| Mar 2006 | - | $25.75M(+557.9%) | $7.94M(+133.9%) |
| Dec 2005 | -$23.40M(-27.0%) | -$5.62M(+9.9%) | -$23.40M(-0.4%) |
| Sep 2005 | - | -$6.24M(-4.9%) | -$23.30M(-11.2%) |
| Jun 2005 | - | -$5.95M(-6.7%) | -$20.94M(-6.5%) |
| Mar 2005 | - | -$5.58M(-0.9%) | -$19.66M(-6.7%) |
| Dec 2004 | -$18.43M(-63.8%) | -$5.53M(-42.1%) | -$18.43M(-17.9%) |
| Sep 2004 | - | -$3.89M(+16.8%) | -$15.63M(-5.8%) |
| Jun 2004 | - | -$4.67M(-7.6%) | -$14.77M(-14.4%) |
| Mar 2004 | - | -$4.34M(-59.3%) | -$12.91M(-14.8%) |
| Dec 2003 | -$11.25M(+32.9%) | -$2.73M(+10.2%) | -$11.25M(-4.4%) |
| Sep 2003 | - | -$3.03M(-8.0%) | -$10.77M(+3.0%) |
| Jun 2003 | - | -$2.81M(-4.8%) | -$11.10M(+15.7%) |
| Mar 2003 | - | -$2.68M(-19.1%) | -$13.17M(+21.5%) |
| Dec 2002 | -$16.77M(-31.4%) | -$2.25M(+33.1%) | -$16.77M(+9.7%) |
| Sep 2002 | - | -$3.36M(+31.1%) | -$18.58M(-0.5%) |
| Jun 2002 | - | -$4.88M(+22.3%) | -$18.49M(-14.1%) |
| Mar 2002 | - | -$6.28M(-54.9%) | -$16.20M(-26.9%) |
| Dec 2001 | -$12.76M(-116.3%) | -$4.06M(-23.9%) | -$12.76M(-10.0%) |
| Sep 2001 | - | -$3.27M(-26.4%) | -$11.60M(-2.2%) |
| Jun 2001 | - | -$2.59M(+8.8%) | -$11.34M(-4.8%) |
| Mar 2001 | - | -$2.84M(+1.7%) | -$10.82M(-83.4%) |
| Dec 2000 | -$5.90M(-0.0%) | -$2.89M(+4.3%) | -$5.90M(-54.9%) |
| Sep 2000 | - | -$3.02M(-46.2%) | -$3.81M(-27.5%) |
| Jun 2000 | - | -$2.07M(-199.5%) | -$2.99M(-192.5%) |
| Mar 2000 | - | $2.08M(+359.8%) | -$1.02M(+82.7%) |
| Dec 1999 | -$5.90M(-28.3%) | -$800.00K(+63.6%) | -$5.90M(-490.0%) |
| Sep 1999 | - | -$2.20M(-2100.0%) | -$1.00M(+41.2%) |
| Jun 1999 | - | -$100.00K(+96.4%) | -$1.70M(+63.0%) |
| Mar 1999 | - | -$2.80M(-168.3%) | -$4.60M(0.0%) |
| Dec 1998 | -$4.60M(+59.6%) | $4.10M(+241.4%) | -$4.60M(+61.0%) |
| Sep 1998 | - | -$2.90M(+3.3%) | -$11.80M(-2.6%) |
| Jun 1998 | - | -$3.00M(-7.1%) | -$11.50M(-7.5%) |
| Mar 1998 | - | -$2.80M(+9.7%) | -$10.70M(+6.1%) |
| Dec 1997 | -$11.40M(-60.6%) | -$3.10M(-19.2%) | -$11.40M(-14.0%) |
| Sep 1997 | - | -$2.60M(-18.2%) | -$10.00M(-2.0%) |
| Jun 1997 | - | -$2.20M(+37.1%) | -$9.80M(-14.0%) |
| Mar 1997 | - | -$3.50M(-105.9%) | -$8.60M(-21.1%) |
| Dec 1996 | -$7.10M(+10.1%) | -$1.70M(+29.2%) | -$7.10M(-1.4%) |
| Sep 1996 | - | -$2.40M(-140.0%) | -$7.00M(-7.7%) |
| Jun 1996 | - | -$1.00M(+50.0%) | -$6.50M(+3.0%) |
| Mar 1996 | - | -$2.00M(-25.0%) | -$6.70M(+15.2%) |
| Dec 1995 | -$7.90M(-14.5%) | -$1.60M(+15.8%) | -$7.90M(0.0%) |
| Sep 1995 | - | -$1.90M(-58.3%) | -$7.90M(+1.3%) |
| Jun 1995 | - | -$1.20M(+62.5%) | -$8.00M(+3.6%) |
| Mar 1995 | - | -$3.20M(-100.0%) | -$8.30M(-20.3%) |
| Dec 1994 | -$6.90M | -$1.60M(+20.0%) | -$6.90M(-30.2%) |
| Sep 1994 | - | -$2.00M(-33.3%) | -$5.30M(-60.6%) |
| Jun 1994 | - | -$1.50M(+16.7%) | -$3.30M(-83.3%) |
| Mar 1994 | - | -$1.80M | -$1.80M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of BCRX is -$53.14M
What is the all-time high annual free cash flow for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual free cash flow is -$4.60M
What is BioCryst Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, BCRX annual free cash flow has changed by +$44.16M (+45.39%)
What is BioCryst Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of BCRX is $41.12M
What is the all-time high quarterly free cash flow for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly free cash flow is $41.12M
What is BioCryst Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, BCRX quarterly free cash flow has changed by +$42.65M (+2800.13%)
What is BioCryst Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of BCRX is $15.76M
What is the all-time high TTM free cash flow for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM free cash flow is $15.76M
What is BioCryst Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, BCRX TTM free cash flow has changed by +$101.56M (+118.37%)